Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 2/20 | 0.73 |
| ▸ | IKBKB | O14920 | 1/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.65 |
| ▸ | GLA | P06280 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | HPGD | P15428 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | ATM | Q13315 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.62 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.59 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.59 |
| ▸ | PRNP | P04156 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
| ▸ | OGG1 | O15527 | 1/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6609258 | 0.85 | LIMK1 (1.00) | LIMK1IKBKBKDM4EMEN1ALDH1A1 | |
| SCHEMBL16581218 | 0.84 | GABRA1 (0.77) | LIMK1IKBKBKDM4EMEN1ALDH1A1 | |
| SCHEMBL15766514 | 0.83 | LIMK1 (0.71) | LIMK1IKBKBKDM4EMEN1ALDH1A1 | |
| SCHEMBL29285354 | 0.80 | OGG1 (0.69) | LIMK1IKBKBKDM4EMEN1ALDH1A1 | |
| SCHEMBL30173777 | 0.79 | KDM4E (1.00) | LIMK1IKBKBKDM4EMEN1ALDH1A1 | |
| SCHEMBL3828429 | 0.79 | ALDH1A1 (0.67) | LIMK1IKBKBKDM4EMEN1ALDH1A1 | |
| SCHEMBL1101766 | 0.79 | KDM4E (1.00) | LIMK1IKBKBKDM4EMEN1ALDH1A1 | |
| SCHEMBL16581289 | 0.79 | GABRA1 (0.74) | LIMK1IKBKBKDM4EMEN1ALDH1A1 | |
| SCHEMBL941112 | 0.78 | MCL1 (0.65) | LIMK1IKBKBKDM4EMEN1ALDH1A1 | |
| SCHEMBL29664668 | 0.78 | MCL1 (0.65) | LIMK1IKBKBKDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025093589-A1 | HETEROARYL AMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2025-05-08 | — | — | WO | disclosed |
| CN-112851732-B | Method for synthesizing On-DNA 2-carboxyl-3-amino arylthiophene compound | 成都先导药物开发股份有限公司 | 2023-03-07 | — | — | CN | disclosed |
| CN-112851732-A | Method for synthesizing On-DNA 2-carboxyl-3-amino arylthiophene compound | 成都先导药物开发股份有限公司 | 2021-05-28 | — | — | CN | disclosed |
| US-9955689-B2 | Method for promoting plant growth | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9955689-B2 | Method for promoting plant growth | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-01 | — | — | US | disclosed |
| US-9955689-B2 | Method for promoting plant growth | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-01 | — | — | US | disclosed |
| US-20160322585-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2016-11-03 | — | — | US | disclosed |
| US-20150289506-A1 | METHOD FOR PROMOTING PLANT GROWTH | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-10-15 | — | — | US | disclosed |
| US-20150289506-A1 | METHOD FOR PROMOTING PLANT GROWTH | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-10-15 | — | — | US | disclosed |
| US-20150289506-A1 | METHOD FOR PROMOTING PLANT GROWTH | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-10-15 | — | — | US | disclosed |
| WO-2002000653-A2 | FUSED CYCLIC COMPOUNDS AS MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-01-03 | — | — | WO | disclosed |
| EP-0942911-A1 | BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE ALPHA-1 ADRENERGIC COMPOUNDS | Abbott Laboratories (US) | 1999-09-22 | — | — | EP | disclosed |
| WO-1998024791-A1 | BENZOPYRANOPYRROLE AND BENZOPYRANOPYRIDINE ALPHA-1 ADRENERGIC COMPOUNDS | ABBOTT LABORATORIES (US) | 1998-06-11 | — | — | WO | disclosed |
| EP-0817635-A1 | USE OF THIAZEPINE, OXAZEPINE AND DIAZEPINE COUMPOUNDS FOR INHIBITING HIV, HERPESVIRUS AND SUPPRESSING THE IMMUNE SYSTEM | WARNER-LAMBERT COMPANY LLC (US) | 1998-01-14 | — | — | EP | disclosed |
| EP-0772612-A1 | 4-HYDROXY-3-PHENYL-INDENO(1,2-B)PYRIDINE-2(1H)-ONE DERIVATIVES AS NMDA ANTAGONISTS | Aventis Pharma S.A. (FR) | 1997-05-14 | — | — | EP | disclosed |
| EP-0749434-A1 | BENZOTHIOPHENE, BENZOFURAN AND INDOLETHIAZEPINONES, OXAZEPINONES AND DIAZEPINONES AS INHIBITORS OF CELL ADHESION AND AS INHIBITORS OF HIV | WARNER-LAMBERT COMPANY (US) | 1996-12-27 | — | — | EP | disclosed |
| WO-1996029077-A1 | USE OF THIAZEPINE, OXAZEPINE AND DIAZEPINE COUMPOUNDS FOR INHIBITING HIV, HERPESVIRUS AND SUPPRESSING THE IMMUNE SYSTEM | WARNER-LAMBERT COMPANY (US) | 1996-09-26 | — | — | WO | disclosed |
| WO-1996002536-A1 | 4-HYDROXY-3-PHENYL-INDENO(1,2-B)PYRIDINE-2(1H)-ONE DERIVATIVES AS NMDA ANTAGONISTS | RHONE-POULENC RORER S.A. (FR) | 1996-02-01 | — | — | WO | disclosed |
| WO-1995024408-A1 | BENZOTHIOPHENE, BENZOFURAN AND INDOLETHIAZEPINONES, OXAZEPINONES AND DIAZEPINONES AS INHIBITORS OF CELL ADHESION AND AS INHIBITORS OF HIV | WARNER-LAMBERT COMPANY (US) | 1995-09-14 | — | — | WO | disclosed |
| US-4257942-A | New water-insoluble azo dyes | AZIENDE COLORI NAZIONALI AFFINI ACNA S.P.A. (IT) | 1981-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150289506-A1 | METHOD FOR PROMOTING PLANT GROWTH | FGF2, BROX, BOLA2; BOLA2B | LIMK1 4672/4885IKBKB 2375/4885KDM4E 778/4885 |
| US-20160322585-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | LIMK1 1225/4885IKBKB 2327/4885KDM4E 3045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.